COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review
- PMID: 33733422
- PMCID: PMC7969349
- DOI: 10.1007/s11356-021-13018-1
COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review
Abstract
Diseases negatively impact the environment, causing many health risks and the spread of pollution and hazards. A novel coronavirus, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has led to a recent respiratory syndrome epidemic in humans. In December 2019, the sudden emergence of this new coronavirus and the subsequent severe disease it causes created a serious global health threat and hazards. This is in contrast to the two aforementioned coronaviruses, SARS-CoV-2 (in 2002) and middle east respiratory syndrome coronavirus MERS-CoV (in 2012), which were much more easily contained. The World Health Organization (WHO) dubbed this contagious respiratory disease an "epidemic outbreak" in March 2020. More than 80 companies and research institutions worldwide are working together, in cooperation with many governmental agencies, to develop an effective vaccine. To date, six authorized vaccines have been registered. Up till now, no approved drugs and drug scientists are racing from development to clinical trials to find new drugs for COVID-19. Wild animals, such as snakes, bats, and pangolins are the main sources of coronaviruses, as determined by the sequence homology between MERS-CoV and viruses in these animals. Human infection is caused by inhalation of respiratory droplets. To date, the only available treatment protocol for COVID-19 is based on the prevalent clinical signs. This review aims to summarize the current information regarding the origin, evolution, genomic organization, epidemiology, and molecular and cellular characteristics of SARS-CoV-2 as well as the diagnostic and treatment approaches for COVID-19 and its impact on global health, environment, and economy.
Keywords: Antiviral drugs; Disease prevention; Pathology; SARS-CoV-2; Therapies; Vaccines.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.Cochrane Database Syst Rev. 2019 Oct 23;10(10):ED000141. doi: 10.1002/14651858.ED000141. Cochrane Database Syst Rev. 2019. PMID: 31643081 Free PMC article.
-
Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2024 Oct;28(75):1-75. doi: 10.3310/TGAC4201. Health Technol Assess. 2024. PMID: 39487741 Free PMC article.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD007807. doi: 10.1002/14651858.CD007807.pub4. Cochrane Database Syst Rev. 2020. PMID: 32851663 Free PMC article.
-
Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.Aesthetic Plast Surg. 2024 Oct;48(20):4217-4227. doi: 10.1007/s00266-024-04260-2. Epub 2024 Aug 5. Aesthetic Plast Surg. 2024. PMID: 39103642 Review.
Cited by
-
The Effect of Pomegranate Juice and Sumac Consumption in the Treatment of Outpatients with COVID-19.Mediators Inflamm. 2022 Nov 30;2022:6850342. doi: 10.1155/2022/6850342. eCollection 2022. Mediators Inflamm. 2022. PMID: 36505757 Free PMC article. Clinical Trial.
-
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.Saudi J Biol Sci. 2022 Apr;29(4):1981-1997. doi: 10.1016/j.sjbs.2021.12.020. Epub 2021 Dec 13. Saudi J Biol Sci. 2022. PMID: 34924802 Free PMC article. Review.
-
Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine.Vaccines (Basel). 2022 Oct 10;10(10):1689. doi: 10.3390/vaccines10101689. Vaccines (Basel). 2022. PMID: 36298554 Free PMC article. Review.
-
Investigational antiviral drugs for the treatment of COVID-19 patients.Arch Virol. 2022 Mar;167(3):751-805. doi: 10.1007/s00705-022-05368-z. Epub 2022 Feb 9. Arch Virol. 2022. PMID: 35138438 Review.
-
ICT-Guided Glycemic Information Sharing Through Artificial Neural Telecare Network.SN Comput Sci. 2021;2(6):426. doi: 10.1007/s42979-021-00818-y. Epub 2021 Aug 23. SN Comput Sci. 2021. PMID: 34458859 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous